Methods for producing modified glycoproteins

Details Methods for producing modified glycoproteins Methods for producing modified glycoproteins

2006-04-18

2006-04-18

Qian, Celine (Department: 1636)

Chemistry: molecular biology and microbiology

Micro-organism, tissue cell culture or enzyme using process...

Recombinant dna technique included in method of making a...

C435S254200, C435S455000, C435S320100

Reexamination Certificate

active

07029872

ABSTRACT:
Cell lines having genetically modified glycosylation pathways that allow them to carry out a sequence of enzymatic reactions, which mimic the processing of glycoproteins in humans, have been developed. Recombinant proteins expressed in these engineered hosts yield glycoproteins more similar, if not substantially identical, to their human counterparts. Thelower eukaryotes, which ordinarily produce high-mannose containing N-glycans, including unicellular and multicellular fungi are modified to produce N-glycans such as Man5GlcNAc2or other structures along human glycosylation pathways. This is achieved using a combination of engineering and/or selection of strains which: do not express certain enzymes which create the undesirable complex structures characteristic of the fungal glycoproteins, which express exogenous enzymes selected either to have optimal activity under the conditions present in the fungi where activity is desired, or which are targeted to an organelle where optimal activity is achieved, and combinations thereof wherein the genetically engineered eukaryote expresses multiple exogenous enzymes required to produce “human-like” glycoproteins.

REFERENCES:
patent: 4414329 (1983-11-01), Wegner
patent: 4617274 (1986-10-01), Wegner
patent: 4683293 (1987-07-01), Craig
patent: 4775622 (1988-10-01), Hitzeman et al.
patent: 4808537 (1989-02-01), Stroman et al.
patent: 4812405 (1989-03-01), Lair et al.
patent: 4818700 (1989-04-01), Cregg et al.
patent: 4837148 (1989-06-01), Cregg
patent: 4855231 (1989-08-01), Stroman et al.
patent: 4857467 (1989-08-01), Sreekrishna et al.
patent: 4879231 (1989-11-01), Stroman et al.
patent: 4882279 (1989-11-01), Cregg
patent: 4885242 (1989-12-01), Cregg
patent: 4925796 (1990-05-01), Bergh et al.
patent: 4929555 (1990-05-01), Cregg et al.
patent: 4935349 (1990-06-01), McKnight et al.
patent: 5002876 (1991-03-01), Sreekrishna et al.
patent: 5004688 (1991-04-01), Craig et al.
patent: 5032516 (1991-07-01), Cregg
patent: 5032519 (1991-07-01), Paulson et al.
patent: 5047335 (1991-09-01), Paulson et al.
patent: 5122465 (1992-06-01), Cregg et al.
patent: 5135854 (1992-08-01), MacKay et al.
patent: 5166329 (1992-11-01), Cregg
patent: 5324663 (1994-06-01), Lowe
patent: 5595900 (1997-01-01), Lowe
patent: 5602003 (1997-02-01), Pierce et al.
patent: 5707828 (1998-01-01), Sreekrishna et al.
patent: 5766910 (1998-06-01), Fukuda et al.
patent: 5834251 (1998-11-01), Maras et al.
patent: 5849904 (1998-12-01), Gerardy-Schahn et al.
patent: 5854018 (1998-12-01), Hitzeman et al.
patent: 5861293 (1999-01-01), Kojiri et al.
patent: 5910570 (1999-06-01), Elhammer et al.
patent: 5945314 (1999-08-01), Prieto et al.
patent: 5945322 (1999-08-01), Gotschlich
patent: 5955347 (1999-09-01), Lowe
patent: 5955422 (1999-09-01), Lin
patent: 5962294 (1999-10-01), Paulson et al.
patent: 6017743 (2000-01-01), Tsuji et al.
patent: 6096512 (2000-08-01), Elhammer et al.
patent: 6204431 (2001-03-01), Prieto et al.
patent: 0 905 232 (1999-03-01), None
patent: 1 054 062 (2000-11-01), None
patent: 1 211 310 (2002-06-01), None
patent: WO 96/21038 (1996-07-01), None
patent: WO 98/05768 (1998-02-01), None
patent: WO 99/31224 (1999-06-01), None
patent: WO 99/54342 (1999-10-01), None
patent: WO 01/14522 (2001-03-01), None
patent: WO 01/25406 (2001-04-01), None
patent: WO 02/00856 (2002-01-01), None
Choi et al. PNAS 2003, vol. 100, No. 9, pp. 5022-5027.
Nakayama, et al., “OCH1 encodes a novel membrane bound mannosyltransferase outer chain elongation of asparagine-linged oligosaccharides,”EMBO Journal11 (7): 2511-2519 (1992).
Nikawa, et al., “Structural and functional conversation of human and yeast HCP1 genese which can suppress the growth defect of theSaccharomyces cerevisiae ire15mutant,”Gene171(1): 107-111 (1996).
Wiggins, et al., “Activity of the yeast MNN1 alpha-1,3-mannosyltransferase requires a motif conserved in many other families of glycosyltransferases,”Proc. Nat. Acad. Sci. USA95(14): 7945-7950 (1998).
Altmann, et al., “Processing of asparagine-linked oligosaccharides in insect cells: evidence for alpha-mannosidase II,”Glycoconj. J12(2):150-155 (1995).
Altmann, et al., “Insect cells as hosts for the expression of recombinant glycoproteins,”Glycoconj. J. 16(2):109-123 (1999).
Andersen, et al., “The effect of cell-culture conditions on the oligosaccharide structures of secreted glycoproteins,”Cur. Opin.Biotechnol5(5) 546-549 (1994).
Aoki, et al., “Expression and activity of chimeric molecules between human UDP-galactose transporter and CMP-sialic acid transporter,”J Biochem(Tokyo) 126(5): 940-950 (1999).
Bardor, et al., “Analysis of the N-glycosylation of recombinant glycoproteins produced in transgenic plants,”Trends in Plant Science4(9): 376-380 (1999).
Beaudet, et al., “High-level expression of mouse Mdr3 P-glycoprotein in yeastPichia pastorisand Characterization of ATPase activity,” Methods Enzymol 292: 397-413 (1998).
Berka, et al., “The Filamentous Fungus Aspergillus-Niger Var Awamori as Host for the Expression and Secretion of Fungal and Non-Fungal Heterologous Proteins,”Abstr Papers Amer Chem Soc203: 121-BIOT (1992).
Berninsone, et al., “Functional expression of the murine Golgi CMP-sialic acid transporter inSaccharomyces cerevisiae,”J. Biol.Chem.272(19):12616-12619 (1997).
Berninsone, et al., “Regulation of yeast Golgi glycosylation. Guanosine diphosphatase functions as a homodimer in the membrane,”J. Biol. Chem270(24): 14564-14567 (1995).
Berninsone, et al., “The Golgi guanosine diphosphatase is required for transport of GDP-mannose into the lumen ofSaccharomyces cerevisiaeGolgi vesicles,”J. Biol. Chem269(1):207-211 (1994).
Bonneaud, et al., “A family of low and high copy replicative, integrative and single-strandedS. cerevisiae/E. colishuttle vectors,”Yeast7(6): 609-615 (1991).
Bretthauer, et al., “Glycosylation ofPichia pastoris-derived proteins,”Biotechnol Appl Biochem30(Pt 3): 193-200 (1999).
Cereghino, et al., “Heterologous protein expression in the methylotrophic yeastPichia pastoris,” FEMS Microbiol Rev24(1): 45-66 (2000).
Chandrasekaran, et al., “Purification and properties of alpha-D-mannose:beta-1,2-N-acetylglucosaminyl-transferases and alpha-D-mannosidases from human adenocarcinoma,” Cancer Res. 44(9):4059-68 (1984).
Chiba, et al., “Production of human compatible high mannose-type (Man5GlcNAc2) sugar chains inSaccharomyces cerevisiae,” J. Biol. Chem273(41):26298-26304 (1998).
Cole, et al., “Modelling with growth, survival and death of microorganisms in foods: the UK food micromodel approach,”J Cell.Biochem23(3-4) 265-265 (1994).
Dente, “Human alpha-1-acid glycoprotein genes,”Prog. Clin. Biol. Res300:85-98 (1989).
Eades, et al., “Characterization of the class 1 alpha-mannosidase gene family in the filamentous fungusAspergillus nidulans,”Gene255(1):25-34 (2000).
Eckhardt, et al., “Molecular cloning of the hamster CMP-sialic acid transporter,”Eur. J. Biochem. 248(1): 187-192 (1997).
Graham, et al., “Compartmental organization of Golgi-specific protein modification and vacuolar protein sorting events defined in a yeast sec18 (NSF) mutant,”J. Cell. Biol. 114(2):207-218 (1991).
Guillen, et al., “Mammalian Golgi apparatus UDP-N-acetylglucosamine transporter: molecular cloning by phenotypic correction of a yeast mutant,”Proc. Natl.Acad. Sci.USA95(14): 7888-7892 (1998).
Harkki, et al., “A Novel Fungal Expression System—Secretion of Active Calf Chymosin from the Filamentous Fungus Trichoderma-Reesei.”Bio-Tech7:596-603 (1989).
Ichishima, et al., “Molecular and enzymic properties of recombinant 1, 2-alpha-mannosidase fromAspergillus saitoioverexpressed inAspergillus oryzaecells,”Biochem. J. 339(Pt 3):589-597 (1999).
Ishida, et al., “Molecular cloning and functional expression of the human G

Affiliated with

Also associated with

Rating

Methods for producing modified glycoproteins does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods for producing modified glycoproteins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for producing modified glycoproteins will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3544883